PERMED

Personalized Medicine 2020 and beyond – Preparing Europe for leading the global way

Activity Code: HEALTH.2013.4.1-4
Project Reference: 602139
Coordinator: Deutsches Zentrum für Luft- und Raumfahrt

Description:

The Health Directorate of the European Commission's DG Research and Innovation recently stated that Personalized Medicine is one of the most innovative areas in the future of health research with a high potential for patients, citizens and the economy. However, today the full potential cannot be developed due to fragmented activities, insufficient communication and lack of generic solutions in the different areas of Personalized Medicine.The implementation of Personalized Medicine is, therefore, a major challenge in Europe and beyond. It calls for appropriate governance strategies at the European and global level as it challenges the way in which healthcare systems worldwide are set up. Thus, the EC itself, EuroBioForum, the European Health Forum Gastein (EHFG) and others have organized conferences to tackle these challenges.
Furthermore, key European organizations and institutions have come up with reports, guidelines, roadmaps aiming to give guidance in this emerging and important health research field amongst others the European Science Foundation (ESF) Forward Look, the Manifesto of the European Alliance for Personalised Medicine (EAPM), the European Best Practice Guidelines of the Public Health Genomics European Network (PHGEN), the Roche report on Personalized Medicine or the report of the European Hospital and Healthcare Federation (HOPE). Based on these initiatives European and national decision-makers and funding bodies not only have expressed the urgent need for a CSA, but also initiated this specific CSA to step up coordination efforts between the European key stakeholders to allow synergies and avoid duplication or competition, to ensure maximum transparency and openness preparing Europe for leading the global way.

Partners:

  • Fundacion Vasca De Innovacion E Investigacion Sanitarias, España
  • Bundesministerium fuer Bildung Und Forschung, Deutschland
  • Fondation Europeenne De La Science, France
  • Internationales Forum Gastein Verein, Österreich
  • Commissariat A L Energie Atomique Et Aux Energies Alternatives, France
  • Societe Europeenne De Pharmacogenomique Et Theranostique - European Society Of Pharmacogenomics And Theranostics Association, France
  • Royal Institution For The Advancement Of Learning Mcgill University, Canada
  • Instituto De Salud Carlos Iii, España
  • Helsingin Yliopisto, Finland
  • Universiteit Maastricht, Nederland
  • Bundesinstitut für Arzneimittel und Medizinprodukte, Deutschland
  • Ministero Della Salute, Italia
  • Ministry Of Health, Israel
  • Institut National Du Cancer, France
  • Zorgonderzoek Nederland Zon, Nederland
  • Fonds National De La Recherche, Luxembourg
  • Medical Research Council, United Kingdom
Print Version

More information

The project in CORDIS

 

Project details

Start Date: 2013-09-01
End Date:   2015-08-31
EU Contribution:
EUR 497 378
Total Costs:
EUR 645 115
Funding Scheme:
Support actions
Adm. Contact Person:

Silke KRAUS
Programme Acronym: FP7-HEALTH
Subprogramme Area: HEALTH.2013.4.1-4